The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Open accessAbstract
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes. Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of α-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent upon increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the region of chromosome 1p12 encoding PHGDH is amplified in a significant fraction of tumors”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Functional PHGDH loss is toxic to tumor cells with PHGDH amplification or high serine biosynthetic flux (Locasale et al., 2011; Mattaini et al., 2015; Possemato et al., 2011; Zhang et al., 2017), and small-molecule inhibitors targeting PHGDH have been shown to inhibit serine synthesis and tumor proliferation in vitro and in xenograft cancer models (Mullarky et al., 2016; Pacold et al., 2016; Wang”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Serine is present in plasma and can be taken up by cells via amino acid transporters, yet PHGDH expression and increased serine biosynthesis have been shown to be important for supporting cancer cell proliferation and survival in both in vitro and in vivo settings (Locasale et al., 2011; Possemato et al., 2011).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“More recently, it was found that increased expression of the serine synthesis enzyme phosphoglycerate dehydrogenase (PHGDH) in some cancers can result from copy number gain of a region on chromosome 1p (Beroukhim et al., 2010; Locasale et al., 2011; Possemato et al., 2011) or a consequence of oncogenic signaling, including NRF2 and ATF4 signaling (DeNicola et al., 2015), or hypoxia responses (Sam”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Possemato et al., 2011
In the citing paper
“Amplification of PHGDH has been observed in breast cancer and melanoma (65), and increased PHGDH expression can promote both enhanced serine biosynthesis and the proliferation of cancer cells (65, 66).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [66]
In the citing paper
“cell lines derived from these tumors tend to be highly dependent on PHGDH expression”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation (1,2).”
Self-citationRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J. H., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,515
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S. E., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.020 · Cited by 1,405
Cited by
Sorted by citations
Items 601–700 of 1,000
Marani, M., Paone, A., Fiascarelli, A., Macone, A., Gargano, M., Rinaldo, S., Giardina, G., Pontecorvi, V., Koes, D. R., McDermott, L. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6726 · Cited by 57
The metabolic axis of macrophage and immune cell polarization
Hobson-Gutierrez, S., & Carmona‐Fontaine, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034462 · Cited by 57
Lionaki, E., Gkikas, I., Daskalaki, I., Ioannidi, M.-K., Klapa, M. I., & Tavernarakis, N. (2022) · Nature Communications · doi:10.1038/s41467-022-28272-1 · Cited by 56
Itoyama, R., Yasuda‐Yoshihara, N., Kitamura, F., Yasuda, T., Bu, L., Yonemura, A., Uchihara, T., Arima, K., Hu, X., Zhang, J., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.007 · Cited by 56
Tombari, C., Zannini, A., Bertolio, R., Pedretti, S., Audano, M., Triboli, L., Cancila, V., Vacca, D., Caputo, M., Donzelli, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42458-1 · Cited by 57
Recent progress in immune evasion mechanisms of triple-negative breast cancer
Yang, Y., & Wang, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07370-w · Cited by 56
Sen, N., Cross, A. M., Lorenzi, P. L., Khan, J. I., Gryder, B. E., Kim, S., & Caplen, N. J. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22849 · Cited by 56
de Araújo, L. F., Siena, Á. D. D., Plaça, J. R., Brotto, D. B., de Barros, I. I., Muys, B. R., de Biagi, C. A. O., Peronni, K. C., Sousa, J. F., de Molfetta, G. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31170-6 · Cited by 56
Birts, C. N., Banerjee, A., Darley, M., Dunlop, C. R., Nelson, S., Nijjar, S. K., Parker, R., West, J. J., Tavassoli, A., Rose-Zerilli, M. J. J., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aau9529 · Cited by 56
Endogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 56
Self-citationA retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism
Zhao, J.-Y., Feng, K., Wang, F., Zhang, J., Cheng, J. F., Lin, G., Gao, D., & Tian, P. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113379 · Cited by 56
The phosphorylated pathway of serine biosynthesis links plant growth with nitrogen metabolism
Zimmermann, S. E., Benstein, R. M., Flores‐Tornero, M., Blau, S., Anoman, A. D., Rosa‐Téllez, S., Gerlich, S. C., Salem, M. A., Alseekh, S., Kopřiva, S., et al. (2021) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiab167 · Cited by 55
The Role of Reprogrammed Glucose Metabolism in Cancer
Ediriweera, M. K., & Jayasena, S. (2023) · Metabolites · doi:10.3390/metabo13030345 · Cited by 55
The why and how of amino acid analytics in cancer diagnostics and therapy
Manig, F., Kuhne, K., von Neubeck, C., Schwarzenbolz, U., Yu, Z., Kessler, B. M., Pietzsch, J., & Kunz‐Schughart, L. A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.12.001 · Cited by 55
Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression
Weber, G. F. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00257 · Cited by 56
Lane, A. N., Tan, J. D., Wang, Y., Yan, J., Higashi, R. M., & Fan, T. W. ‐. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.01.010 · Cited by 55
Serine-Dependent Sphingolipid Synthesis Is a Metabolic Liability of Aneuploid Cells
Hwang, S., Gustafsson, H. T., O’Sullivan, C., Bisceglia, G., Huang, X., Klose, C. D., Schevchenko, A., Dickson, R. C., Cavaliere, P., Dephoure, N., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.103 · Cited by 55
Feist, M., Schwarzfischer, P., Heinrich, P., Sun, X., Kemper, J., von Bonin, F., Pérez-Rubio, P., Taruttis, F., Rehberg, T., Dettmer, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03803-x · Cited by 55
Suganuma, T., & Workman, J. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012634 · Cited by 55
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56
Yu, W., Chen, Y., Putluri, N., Coarfa, C., Robertson, M. J., Putluri, V., Stossi, F., Dubrulle, J., Mancini, M. A., Pang, J. C., et al. (2020) · Cancers · doi:10.3390/cancers12061670 · Cited by 55
D’Alessandro, A., Amelio, I., Berkers, C. R., Antonov, A., Vousden, K. H., Melino, G., & Zolla, L. (2014) · Oncotarget · doi:10.18632/oncotarget.2300 · Cited by 54
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54
Wang, J., Zhang, P., Zhong, J., Tan, M., Ge, J., Tao, L., Li, Y., Zhu, Y., Wu, L., Qiu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8382 · Cited by 55
Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
Zhang, X., & Bai, W. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3117-4 · Cited by 54
Supply and demand: Cellular nutrient uptake and exchange in cancer
Papalazarou, V., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.026 · Cited by 53
Metabolic Profiling, a Noninvasive Approach for the Detection of Experimental Colorectal Neoplasia
Montrose, D. C., Zhou, X. K., Kopelovich, L., Yantiss, R. K., Karoly, E. D., Subbaramaiah, K., & Dannenberg, A. J. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0160 · Cited by 53
On the phenotypic spectrum of serine biosynthesis defects
El‐Hattab, A. W., Shaheen, R., Hertecant, J., Galadari, H., Albaqawi, B. S., Nabil, A., & Alkuraya, F. S. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9921-5 · Cited by 53
Functional and Metabolomic Consequences of KATP Channel Inactivation in Human Islets
Li, C., Ackermann, A. M., Boodhansingh, K. E., Bhatti, T. R., Liu, C., Schug, J., Doliba, N. M., Han, B., Cosgrove, K. E., Banerjee, I., et al. (2017) · Diabetes · doi:10.2337/db17-0029 · Cited by 53
Wei, J., Wu, S.-Y., Yang, Y., Xiao, Y., Jin, X., Xu, X., Hu, X., Li, D., Jiang, Y., & Shao, Z. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002383 · Cited by 53
Shi, Q., Liu, T., Zhang, X., Geng, J., He, X., Nu, M., & Pang, D. (2016) · Oncology Letters · doi:10.3892/ol.2016.5021 · Cited by 52
A Flux Balance of Glucose Metabolism Clarifies the Requirements of the Warburg Effect
Dai, Z., Shestov, A. A., Lai, L., & Locasale, J. W. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.07.028 · Cited by 52
Pan, S., Jang, S., Liew, S. S., Fu, J., Wang, D., Lee, J., & Yao, S. Q. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201710856 · Cited by 52
Menin regulates the serine biosynthetic pathway in Ewing sarcoma
Svoboda, L. K., Teh, S. S. K., Sud, S., Kerk, S. A., Zebolsky, A. L., Treichel, S., Thomas, D. G., Halbrook, C. J., Lee, H., Kremer, D. M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5085 · Cited by 52
NMR and MS-based Stable Isotope-Resolved Metabolomics and applications in cancer metabolism
Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.11.020 · Cited by 52
Mitochondrial functions and melatonin: a tour of the reproductive cancers
Chuffa, L. G. D. A., Seiva, F. R. F., Cucielo, M. S., Silveira, H. S., Reiter, R. J., & Lupi, L. A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2963-0 · Cited by 52
MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma
Zhang, Y., Nguyen, T. T. T., Shang, E., Mela, A., Humala, N., Mahajan, A., Zhao, J., Shu, C., Torrini, C., Sanchez‐Quintero, M. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1389 · Cited by 52
Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma
Cissé, M. Y., Pyrdziak, S., Firmin, N., Gayte, L., Heuillet, M., Bellvert, F., Fuentes, M., Delpech, H., Riscal, R., Arena, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2163 · Cited by 52
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Rathore, R., Caldwell, K. E., Schutt, C. R., Brashears, C. B., Prudner, B. C., Ehrhardt, W. R., Leung, C. H., Lin, H. Y., Daw, N. C., Beird, H. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108678 · Cited by 52
Transporters at the Interface between Cytosolic and Mitochondrial Amino Acid Metabolism
Hewton, K. G., Johal, A. S., & Parker, S. J. (2021) · Metabolites · doi:10.3390/metabo11020112 · Cited by 52
Exploring metabolic pathways that contribute to the stem cell phenotype
Vacanti, N. M., & Metallo, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.007 · Cited by 51
Cabezón, T., Gromova, I., Gromov, P., Serizawa, R., Wielenga, V. T., Kroman, N. T., Celis, J. E., & Moreira, J. M. A. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019786 · Cited by 51
Gupta, R., Yang, Q., Dogra, S. K., & Wajapeyee, N. (2017) · Oncogene · doi:10.1038/onc.2017.37 · Cited by 51
Marchi, T. D., Timmermans, M. A. M., Sieuwerts, A. M., Smid, M., Look, M. P., Grebenchtchikov, N. I., Sweep, F. C. G. J., Smits, J. G., Magdolen, V., van Deurzen, C. H. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02296-w · Cited by 51
Auslander, N., Cunningham, C. E., Toosi, B. M., McEwen, E., Yizhak, K., Vizeacoumar, F. S., Parameswaran, S., Gonen, N., Freywald, T., Bhanumathy, K. K., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177739 · Cited by 51
Tétard‐Jones, C., Sabbadin, F., Moss, S. R., Hull, R. J., Neve, P., & Edwards, R. (2018) · The Plant Journal · doi:10.1111/tpj.13892 · Cited by 51
The decrease of some serum free amino acids can predict breast cancer diagnosis and progression
Eniu, D. T., Romanciuc, F., Moraru, C., Goidescu, I. G., Eniu, D., Staicu, A., Răchieriu, C., Buiga, R., & Socaciu, C. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1542541 · Cited by 51
Sim, W.-C., Lee, W., Sim, H., Lee, K.-Y., Jung, S.-H., Choi, Y., Kim, H., Kang, K. W., Lee, J.-Y., Choi, Y. J., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154000 · Cited by 51
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment
Li, M., Wu, C., Yang, Y., Zheng, M., Yu, S., Wang, J., Chen, L., & Li, H. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00599-9 · Cited by 51
Auslander, N., Yizhak, K., Weinstock, A., Budhu, A., Tang, W., Wang, X. W., Ambs, S., & Ruppin, E. (2016) · Scientific Reports · doi:10.1038/srep29662 · Cited by 50
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 50
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 50
Ravez, S., Spillier, Q., Marteau, R., Féron, O., & Frédérick, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01167 · Cited by 50
Mammary epithelial cells have lineage-rooted metabolic identities
Mahendralingam, M. J., Kim, H., McCloskey, C. W., Aliar, K., Casey, A. E., Tharmapalan, P., Pellacani, D., Ignatchenko, V., García-Valero, M., Palomero, L., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00388-6 · Cited by 50
Yeh, H.-W., Lee, S.-S., Chang, C.-Y., Hu, C., & Jou, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20774 · Cited by 49
Zidi, O., Souai, N., Raies, H., Ayed, F. B., Mézlini, A., Mezrioui, S., Tranchida, F., Sabatier, J., Mosbah, A., Cherif, A., et al. (2021) · Molecules · doi:10.3390/molecules26082266 · Cited by 49
Phenotypic profiling of solute carriers characterizes serine transport in cancer
Papalazarou, V., Newman, A. C., Uribe, A. H., Legrave, N. M., Falcone, M., Zhang, T., McGarry, L., Athineos, D., Shanks, E. J., Blyth, K., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00936-2 · Cited by 53
E-Cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer
Lee, G., Wong, C., Cho, A., West, J. J., Crawford, A. J., Russo, G. C., Si, B. R., Kim, J.-W., Hoffner, L. A., Jang, C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3082 · Cited by 49
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 49
Argininosuccinate lyase is a potential therapeutic target in breast cancer
Huang, H.-L., Chen, W.-C., Hsu, H., Cho, C.-Y., Hung, Y.-H., Wang, C., & Lai, M.-D. (2015) · Oncology Reports · doi:10.3892/or.2015.4280 · Cited by 49
Self-citationMatrix-driven changes in metabolism support cytoskeletal activity to promote cell migration
Wu, Y., Zanotelli, M. R., Zhang, J., & Reinhart‐King, C. A. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.044 · Cited by 49
SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia
Wei, Y., Huang, Y.-H., Skopelitis, D. S., Iyer, S. V., Costa, A. S. H., Yang, Z., Kramer, M., Adelman, E. R., Klingbeil, O., Demerdash, O. E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1849 · Cited by 49
Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis
Ma, Y., Nenkov, M., Chen, Y., Press, A. T., Kaemmerer, E., & Gaßler, N. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1512 · Cited by 49
Targeting the DNA damage response and repair in cancer through nucleotide metabolism
Helleday, T., & Rudd, S. G. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13227 · Cited by 49
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
Gnocchi, D., Sabbà, C., Massimi, M., & Mazzocca, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043710 · Cited by 50
Metabolomic profiling of hormone-dependent cancers: a bird's eye view
Lloyd, S. M., Arnold, J. M., & Sreekumar, A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.001 · Cited by 48
Hirabayashi, Y. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.129 · Cited by 48
Wang, Y., Dong, C., & Zhou, B. P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.09.012 · Cited by 48
Amino Acids in Cancer and Cachexia: An Integrated View
Ragni, M., Fornelli, C., Nisoli, E., & Penna, F. (2022) · Cancers · doi:10.3390/cancers14225691 · Cited by 48
Linking Serine/Glycine Metabolism to Radiotherapy Resistance
Sánchez‐Castillo, A., Vooijs, M., & Kampen, K. R. (2021) · Cancers · doi:10.3390/cancers13061191 · Cited by 47
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
D’Avola, A., Legrave, N. M., Tajan, M., Chakravarty, P., Shearer, R. L., King, H. W., Kluckova, K., Cheung, E. C., Clear, A. J., Gunawan, A. S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153436 · Cited by 47
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
Wang, S., Xiaoxue, Y., Guanbin, S., Yang, L., Junyu, J., & Liu, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.007 · Cited by 47
Yoon, B. K., Kim, H., Oh, T. G., Oh, S. K., Jo, S., Kim, M., Chun, K.-H., Hwang, N., Lee, S., Jin, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217826120 · Cited by 47
Give it or take it: the flux of one‐carbon in cancer cells
Meiser, J., & Vázquez, A. (2016) · FEBS Journal · doi:10.1111/febs.13731 · Cited by 47
Zhang, W., Zhang, M., Gao, C., Zhang, Y., Ge, Y., Guo, S., Guo, X., Zhou, Z., Liu, Q., Zhang, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619034114 · Cited by 47
PHGDH as a mechanism for resistance in metabolically-driven cancers
Rathore, R., Schutt, C. R., & Tine, B. A. V. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.46 · Cited by 47
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
Morrison, A. J. (2021) · FEBS Journal · doi:10.1111/febs.16032 · Cited by 47
Zhang, C., Yu, J.-J., Yang, C., Yuan, Z.-L., Zeng, H., Wang, J., Shang, S., Lv, X.-X., Liu, X.-T., Liu, J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4113 · Cited by 46
Lee, S. E., Park, S., Yi, S., Choi, N. R., Lim, M. A., Chang, J. W., Won, H.-R., Kim, J. R., Ko, H. M., Chung, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45366-0 · Cited by 46
Quantitation of Cellular Metabolic Fluxes of Methionine
Shlomi, T., Fan, J., Tang, B., Kruger, W. D., & Rabinowitz, J. D. (2014) · Analytical Chemistry · doi:10.1021/ac4032093 · Cited by 46
Ser, Z., Gao, X., Johnson, C., Mehrmohamadi, M., Liu, X., Li, S., & Locasale, J. W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.035 · Cited by 46
RNAi screens identify CHD4 as an essential gene in breast cancer growth
D’Alesio, C., Punzi, S., Cicalese, A., Fornasari, L., Furia, L., Riva, L., Carugo, A., Curigliano, G., Criscitiello, C., Pruneri, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12646 · Cited by 46
Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH
Zheng, M., Guo, J., Xu, J., Yang, K., Tang, R., Gu, X., Li, H., & Chen, L. (2019) · Food & Function · doi:10.1039/c9fo00394k · Cited by 46
Rohde, J. M., Brimacombe, K. R., Liu, L., Pacold, M. E., Yasgar, A., Cheff, D. M., Lee, T. D., Rai, G., Baljinnyam, B., Li, Z., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.016 · Cited by 46
Self-citationRamirez‐Peña, E., Arnold, J. M., Shivakumar, V., Joseph, R., Vijay, G. V., den Hollander, P., Bhangre, N., Allegakoen, P., Prasad, R., Conley, Z. C., et al. (2019) · Cancers · doi:10.3390/cancers11101610 · Cited by 46
Biophysical methods in early drug discovery
Holdgate, G. A., Embrey, K. J., Milbradt, A. G., & Davies, G. M. (2019) · ADMET & DMPK · doi:10.5599/admet.733 · Cited by 46
Wu, X., Su, D., Mei, Y., Xu, M., Zhang, H., Wang, Z., Li, L., Peng, L., Jiang, J., Yang, J., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02896-6 · Cited by 46
Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?
Wackerhage, H., Vechetti, I. J., Baumert, P., Gehlert, S., Becker, L., Jaspers, R. T., & de Angelis, M. H. (2022) · Sports Medicine · doi:10.1007/s40279-022-01676-1 · Cited by 46
Kiweler, N., Delbrouck, C., Pozdeev, V. I., Neises, L., Soriano‐Baguet, L., Eiden, K., Xian, F., Benzarti, M., Haase, L., Koncina, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30363-y · Cited by 46
Yu, J., Xiao, F., Guo, Y., Deng, J., Liu, B., Zhang, Q., Li, K., Wang, C., Chen, S., & Guo, F. (2014) · Diabetes · doi:10.2337/db14-1368 · Cited by 46
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Barnabas, G. D., Lee, J. S., Shami, T., Harel, M., Beck, L., Selitrennik, M., Jerby‐Arnon, L., Erez, N., Ruppin, E., & Geiger, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3020 · Cited by 45
Research into cancer metabolomics: Towards a clinical metamorphosis
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45
Monteiro, M. S., Barros, A. S., Pinto, J., Carvalho, M. C., Luís, A. S., Henrique, R., Jerónimo, C., Bastos, M. D. L., Gil, A. M., & de Pinho, P. G. (2016) · Scientific Reports · doi:10.1038/srep37275 · Cited by 45
Kürschner, G., Zhang, Q., Clima, R., Xiao, Y., Busch, J. F., Kilic, E., Jung, K., Berndt, N., Bulik, S., Holzhütter, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22413 · Cited by 45
Sun, L., Zhang, L., Chen, J., Li, C., Sun, H., Wang, J., & Xiao, H. P. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.444 · Cited by 45
Nyen, T. V., Planque, M., van Wagensveld, L., Duarte, J. A. G., Zaal, E. A., Talebi, A., Rossi, M., Körner, P.-R., Rizzotto, L., Moens, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32272-6 · Cited by 45
Liu, N., Chen, L., Yan, M., Tao, Q., Wu, J., Chen, J., Chen, X., Zhang, W., & Peng, C. (2023) · Research · doi:10.34133/research.0127 · Cited by 45
Hennequart, M., Pilley, S. E., Labuschagne, C. F., Coomes, J., Mervant, L., Driscoll, P. C., Legrave, N. M., Lee, Y., Kreuzaler, P. A., Macintyre, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112562 · Cited by 44
Metadata
- Authors
- Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., Chen, W. W., Barrett, F. G., Stransky, N., Tsun, Z.-Y., Cowley, G. S., Barretina, J., Kalaany, N. Y., Hsu, P. P., Ottina, K., Chan, A. M., Yuan, B., Garraway, L. A., Root, D. E., Mino-Kenudson, M., Brachtel, E. F., Driggers, E. M., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Agios Pharmaceuticals (United States) (US)
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Possemato, Richard
- Shaul, Yoav D.
- Pacold, Michael E.
- Kim, Dohoon
- Birsoy, Kıvanç
- Sethumadhavan, Shalini
- Jang, Hyun G.
- Jha, Abhishek K.
- Chen, Walter W.
- Barrett, Francesca G.
- Stransky, Nicolas
- Cowley, Glenn S.
- Barretina, Jordi
- Kalaany, Nada Y.
- Hsu, Peggy P.
- Yuan, Bingbing
- Garraway, Levi A.
- Root, David E.
- Mino-Kenudson, Mari
- Brachtel, Elena F.
- Sabatini, David M.
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7360
- Pages
- 346-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3353325
- OpenAlex
- W2022899908
- Cited by
- 1,683
- References
- 27
- Citations by year
- 2026: 72 · 2025: 111 · 2024: 120 · 2023: 116 · 2022: 138 · 2021: 167 · 2020: 137 · 2019: 126 · 2018: 93 · 2017: 97 · 2016: 125 · 2015: 93 · 2014: 109 · 2013: 72 · 2012: 87
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- W. M. Keck Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health
- National Cancer Institute (CA103866, R01CA103866, R01CA129105)
- National Institute of General Medical Sciences (T32GM007753)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- PHGDH, breast cancer, cancer metabolism, breast cancer xenografts, estrogen receptor-negative breast cancer, alpha-ketoglutarate, glutamine metabolism, TCA cycle, anaplerosis, tumor metabolic reprogramming, anticancer drug targets, cell proliferation
- MeSH terms
- Animals, Breast Neoplasms, Citric Acid Cycle, Humans, Ketoglutaric Acids, Melanoma, Neoplasm Transplantation, Serine, Biomarkers, Tumor, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glutamic Acid, Genomics, RNA Interference, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
